Balance Sheet Terumo Corporation

Equities

4543

JP3546800008

Medical Equipment, Supplies & Distribution

Delayed Japan Exchange Other stock markets 06:51:05 11/03/2026 am IST			5-day change	1st Jan Change
2,067.00 ^JPY	+1.17%		+6.54%	-8.85%

02/03	Shoulder Innovations, Inc. Announces Board and Committee Changes, Effective February 26, 2026	CI
25/02	Galderma Announces Triple Approval of New Restylane Syringe in the EU, the U.S., and Canada	CI

dda877796e224664.rwx1U3V4pCZ2rPwIicau5rwCs2Q7ZuyKAcSwbZDuOXc.23s_JTwC4Vw93p4x4bOfhNN43ywMMrXke4_IGKSBbAT1egIbABrXTRn_nw

Published financial data: TERUMO CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	61TCr	70TCr	82TCr	92TCr	1,03600Cr
Total Revenues	61TCr	70TCr	82TCr	92TCr	1,03600Cr
Cost of Goods Sold, Total	29TCr	33TCr	40TCr	44TCr	48TCr
Gross Profit	33TCr	37TCr	42TCr	48TCr	56TCr
Selling General & Admin Expenses, Total	16TCr	18TCr	21TCr	34TCr	38TCr
R&D Expenses	4.91TCr	5.18TCr	6.16TCr	-	-
Depreciation & Amortization - (IS)	1.91TCr	2.03TCr	2.34TCr	-	-
Other Operating Expenses	61Cr	178.6Cr	-228.4Cr	-323.8Cr	-265.1Cr
Other Operating Expenses, Total	23TCr	25TCr	30TCr	34TCr	38TCr
Operating Income	9.74TCr	12TCr	12TCr	14TCr	18TCr
Interest Expense, Total	-221.2Cr	-163.8Cr	-223Cr	-206.5Cr	-201.6Cr
Interest And Investment Income	54Cr	64Cr	162Cr	251.7Cr	349.2Cr
Net Interest Expenses	-167.4Cr	-100Cr	-61Cr	45Cr	147.6Cr
Income (Loss) On Equity Invest.	-72Cr	44Cr	17Cr	-2Cr	-47Cr
Currency Exchange Gains (Loss)	22Cr	-112.8Cr	-174.1Cr	-59Cr	-420.5Cr
Other Non Operating Income (Expenses)	297.8Cr	160.1Cr	254.2Cr	101Cr	7.2Cr
EBT, Excl. Unusual Items	9.82TCr	12TCr	12TCr	14TCr	18TCr
Restructuring Charges	-69Cr	-164.5Cr	-254.1Cr	-419.8Cr	-151.8Cr
Impairment of Goodwill	-	-	-	-	-559.9Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-50Cr	-47Cr	386Cr	116.2Cr	68Cr
Asset Writedown	-	3.9Cr	-533.8Cr	-126.6Cr	-1.2TCr
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	371.5Cr	-679.6Cr
EBT, Incl. Unusual Items	9.71TCr	11TCr	12TCr	14TCr	15TCr
Income Tax Expense	1.99TCr	2.57TCr	2.68TCr	3.45TCr	3.76TCr
Earnings From Continuing Operations	7.72TCr	8.88TCr	8.93TCr	11TCr	12TCr
Net Income to Company	7.72TCr	8.88TCr	8.93TCr	11TCr	12TCr
Minority Interest	6.7Cr	-	-	-	-
Net Income - (IS)	7.73TCr	8.88TCr	8.93TCr	11TCr	12TCr
Net Income to Common Incl Extra Items	7.73TCr	8.88TCr	8.93TCr	11TCr	12TCr
Net Income to Common Excl. Extra Items	7.73TCr	8.88TCr	8.93TCr	11TCr	12TCr
Per Share Items
Net EPS - Basic	51.16	58.72	59.5	71.5	79.01
Basic EPS - Continuing Operations	51.16	58.72	59.5	71.5	79.01
Basic Weighted Average Shares Outstanding	151.02Cr	151.24Cr	150.12Cr	148.78Cr	148.05Cr
Net EPS - Diluted	51.05	58.69	59.48	71.47	78.99
Diluted EPS - Continuing Operations	51.05	58.69	59.48	71.47	78.99
Diluted Weighted Average Shares Outstanding	151.35Cr	151.33Cr	150.19Cr	148.84Cr	148.09Cr
Normalized Basic EPS	40.71	48.18	50.02	59.4	75.9
Normalized Diluted EPS	40.62	48.15	50	59.38	75.88
Dividend Per Share	14.5	17	20	22	26
Payout Ratio	27.38	26.41	31.23	30.09	30.45
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	15TCr	18TCr	19TCr	20TCr	25TCr
EBITA	9.74TCr	12TCr	12TCr	16TCr	20TCr
EBIT	9.74TCr	12TCr	12TCr	14TCr	18TCr
EBITDAR	-	-	-	20TCr	25TCr
Effective Tax Rate - (Ratio)	20.46	22.43	23.09	24.47	24.32
Total Current Taxes	-	-	-	-	4.88TCr
Total Deferred Taxes	-	-	-	-	-1.12TCr
Normalized Net Income	6.15TCr	7.29TCr	7.51TCr	8.84TCr	11TCr
Interest on Long-Term Debt	-	-	-	206.5Cr	201.6Cr
Non-Cash Pension Expense	20Cr	9.1Cr	1.3Cr	-10Cr	-55Cr
Supplemental Operating Expense Items
Advertising Expense	1.28TCr	1.6TCr	1.87TCr	2.01TCr	2.13TCr
Selling and Marketing Expenses	2.72TCr	3.17TCr	3.71TCr	2.01TCr	2.13TCr
Research And Development Expense From Footnotes	4.91TCr	5.18TCr	6.16TCr	8.36TCr	9.51TCr
Net Rental Expense, Total	-	-	-	92Cr	134Cr
Imputed Operating Lease Interest Expense	-	-	-	5.67Cr	8.96Cr
Imputed Operating Lease Depreciation	-	-	-	86Cr	125.04Cr
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	34Cr	30Cr
Total Stock-Based Compensation	-	-	-	34Cr	30Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	20TCr	21TCr	19TCr	20TCr	22TCr
Short Term Investments	-	-	-	144.5Cr	28Cr
Trading Asset Securities, Total	-	-	-	2.6Cr	5.6Cr
Total Cash And Short Term Investments	20TCr	21TCr	19TCr	21TCr	22TCr
Accounts Receivable, Total	13TCr	14TCr	15TCr	17TCr	17TCr
Other Receivables	51Cr	78Cr	292Cr	1.01TCr	1.15TCr
Total Receivables	13TCr	14TCr	15TCr	18TCr	18TCr
Inventory	18TCr	20TCr	25TCr	29TCr	29TCr
Prepaid Expenses	880Cr	972.3Cr	1.13TCr	1.3TCr	1.43TCr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	954Cr	842.7Cr	960.5Cr	3.61TCr	1.25TCr
Total Current Assets	52TCr	56TCr	61TCr	72TCr	72TCr
Gross Property Plant And Equipment	-	-	-	95TCr	1LCr
Accumulated Depreciation	-	-	-	-53TCr	-56TCr
Net Property Plant And Equipment	30TCr	33TCr	37TCr	42TCr	43TCr
Long-term Investments	3.2TCr	4.61TCr	6.13TCr	3.88TCr	4.29TCr
Goodwill	23TCr	25TCr	27TCr	30TCr	29TCr
Other Intangibles, Total	25TCr	26TCr	27TCr	22TCr	19TCr
Deferred Tax Assets Long-Term	2.37TCr	2.02TCr	2.05TCr	2TCr	3.11TCr
Deferred Charges Long-Term	-	-	-	6.61TCr	5.77TCr
Other Long-Term Assets, Total	40L	40L	40L	4.65TCr	5.46TCr
Total Assets	1,35100Cr	1,47400Cr	1,60200Cr	1,83100Cr	1,82800Cr
Liabilities
Accounts Payable, Total	8.35TCr	8.15TCr	9.77TCr	4.93TCr	5.24TCr
Accrued Expenses, Total	3.22TCr	3.98TCr	4.46TCr	7.83TCr	8.59TCr
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	4.21TCr	112.1Cr	1.12TCr	16TCr	1.5TCr
Current Portion of Leases	630.7Cr	573.6Cr	679.9Cr	735Cr	755Cr
Current Income Taxes Payable	3.23TCr	3.42TCr	4.36TCr	2.65TCr	2.38TCr
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	1.49TCr	1.53TCr	1.4TCr	6.09TCr	5.63TCr
Total Current Liabilities	21TCr	18TCr	22TCr	38TCr	24TCr
Long-Term Debt	22TCr	22TCr	22TCr	7.5TCr	16TCr
Long-Term Leases	2.62TCr	2.73TCr	2.79TCr	2.94TCr	3.16TCr
Unearned Revenue Non Current	-	-	-	151.8Cr	181.4Cr
Pension & Other Post Retirement Benefits	663.9Cr	581.1Cr	470.3Cr	1.36TCr	1.42TCr
Deferred Tax Liability Non Current	1.6TCr	1.27TCr	887Cr	302.5Cr	583.5Cr
Other Non Current Liabilities	1.59TCr	1.3TCr	1.09TCr	267.1Cr	568.2Cr
Total Liabilities	49TCr	46TCr	49TCr	50TCr	46TCr
Common Stock, Total	3.87TCr	3.87TCr	3.87TCr	3.87TCr	3.87TCr
Additional Paid In Capital	5.18TCr	5.19TCr	5.18TCr	5.18TCr	5.17TCr
Retained Earnings	78TCr	85TCr	87TCr	95TCr	1,01600Cr
Treasury Stock	-683.8Cr	-622.9Cr	-1.15TCr	-1.24TCr	-1.49TCr
Comprehensive Income and Other	-212.3Cr	8.09TCr	16TCr	29TCr	28TCr
Total Common Equity	86TCr	1,01200Cr	1,11100Cr	1,32700Cr	1,36900Cr
Minority Interest	-	-	-	-	-
Total Equity	86TCr	1,01200Cr	1,11100Cr	1,32700Cr	1,36900Cr
Total Liabilities And Equity	1,35100Cr	1,47400Cr	1,60200Cr	1,83100Cr	1,82800Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	151.2Cr	151.27Cr	148.93Cr	148.48Cr	147.5Cr
ECS Total Common Shares Outstanding	151.2Cr	151.27Cr	148.92Cr	148.48Cr	147.5Cr
Book Value / Share	566.57	669.23	746.07	893.8	927.85
Tangible Book Value	38TCr	50TCr	57TCr	80TCr	88TCr
Tangible Book Value Per Share	254.51	328.9	384.67	542.16	597.31
Total Debt	29TCr	26TCr	27TCr	27TCr	21TCr
Net Debt	9.23TCr	5.38TCr	7.93TCr	6.22TCr	-824.7Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	176.8Cr	-668.1Cr	-1.49TCr	-3.72TCr	-4.51TCr
Debt Equivalent Oper. Leases	-	-	-	734.4Cr	1.07TCr
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	364.4Cr	413.3Cr	368Cr	241Cr	192.7Cr
Account Code - Inventory Valuation	-	-	-	-	6
Inventories - Raw Materials, Total	4.43TCr	5.67TCr	7.46TCr	8.35TCr	8.35TCr
Inventories - Work In Process, Total	1.51TCr	1.7TCr	2.68TCr	3.34TCr	3.33TCr
Inventories - Finished Goods, Total	12TCr	12TCr	15TCr	17TCr	18TCr
Inventories - Others	-	10L	-	-	-
Land - (BS)	-	-	-	2.78TCr	2.73TCr
Buildings, Total	-	-	-	33TCr	34TCr
Machinery, Total	-	-	-	50TCr	53TCr
Full Time Employees	26.48T	28.29T	30.21T	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	9.71TCr	11TCr	12TCr	11TCr	12TCr
Depreciation & Amortization - CF	5.39TCr	5.89TCr	7.02TCr	4.42TCr	4.89TCr
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	1.94TCr	2.06TCr
Depreciation & Amortization, Total	5.39TCr	5.89TCr	7.02TCr	6.36TCr	6.95TCr
Amortization of Deferred Charges, Total - (CF)	-	-	-	1.31TCr	1.6TCr
(Gain) Loss From Sale Of Asset	50Cr	47Cr	533.3Cr	-116.2Cr	-68Cr
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	341.5Cr	2.25TCr
(Income) Loss On Equity Investments - (CF)	72Cr	-44Cr	-17Cr	2Cr	47Cr
Other Operating Activities, Total	-2.16TCr	-2.96TCr	-2.61TCr	-920.4Cr	39Cr
Change In Accounts Receivable	641.7Cr	-90Cr	-848Cr	-1.64TCr	-461.3Cr
Change In Inventories	-2.2TCr	-816.6Cr	-3.93TCr	-921.1Cr	-1.16TCr
Change In Accounts Payable	-81Cr	5.5Cr	1.05TCr	-499.6Cr	183.9Cr
Change in Other Net Operating Assets	725.9Cr	663.2Cr	-1.06TCr	77Cr	10Cr
Cash from Operations	12TCr	14TCr	12TCr	15TCr	21TCr
Capital Expenditure	-6.23TCr	-5.35TCr	-5.27TCr	-6.07TCr	-6.86TCr
Sale of Property, Plant, and Equipment	1.6Cr	2.6Cr	51Cr	76Cr	259.4Cr
Cash Acquisitions	-337.4Cr	-285.3Cr	-14Cr	-56Cr	-48Cr
Divestitures	-	-	-	335.4Cr	9.2Cr
Sale (Purchase) of Intangible assets	-2.06TCr	-2.06TCr	-1.95TCr	-1.8TCr	-1.37TCr
Investment in Marketable and Equity Securities, Total	95Cr	-152.1Cr	438.6Cr	-625.7Cr	-329.9Cr
Other Investing Activities, Total	-10L	-10L	829.8Cr	20L	98Cr
Cash from Investing	-8.53TCr	-7.85TCr	-5.91TCr	-8.15TCr	-8.25TCr
Short Term Debt Issued, Total	-	-	68Cr	-	-
Long-Term Debt Issued, Total	7TCr	-	-	-	9.98TCr
Total Debt Issued	7TCr	-	68Cr	-	9.98TCr
Short Term Debt Repaid, Total	-4TCr	-	-68Cr	-	-
Long-Term Debt Repaid, Total	-1TCr	-4.07TCr	-124.2Cr	-1.9TCr	-17TCr
Total Debt Repaid	-5TCr	-4.07TCr	-191.9Cr	-1.9TCr	-17TCr
Repurchase of Common Stock	-30L	-30L	-5.01TCr	-1.11TCr	-3.01TCr
Common Dividends Paid	-2.12TCr	-2.35TCr	-2.79TCr	-3.2TCr	-3.56TCr
Common & Preferred Stock Dividends Paid	-2.12TCr	-2.35TCr	-2.79TCr	-3.2TCr	-3.56TCr
Other Financing Activities, Total	-627.8Cr	-675.1Cr	-733.2Cr	-10L	2.54TCr
Cash from Financing	-743.6Cr	-7.09TCr	-8.66TCr	-6.21TCr	-11TCr
Foreign Exchange Rate Adjustments	513.9Cr	1.23TCr	1.02TCr	1.48TCr	-256.5Cr
Miscellaneous Cash Flow Adjustments	-	-	-	-10L	-10L
Net Change in Cash	3.39TCr	448.1Cr	-1.79TCr	1.76TCr	1.7TCr
Supplemental Items
Cash Interest Paid	106.2Cr	131.2Cr	137.2Cr	129.5Cr	170.8Cr
Cash Income Tax Paid (Refund)	2.31TCr	3.05TCr	2.77TCr	4.57TCr	5.13TCr
Levered Free Cash Flow	820.24Cr	3.43TCr	3TCr	807.14Cr	13TCr
Unlevered Free Cash Flow	958.49Cr	3.53TCr	3.14TCr	936.2Cr	14TCr
Change In Net Working Capital	2.23TCr	2.24TCr	4.15TCr	7.68TCr	-1.8TCr
Net Debt Issued / Repaid	2TCr	-4.07TCr	-124.2Cr	-1.9TCr	-6.85TCr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.7	5.16	4.87	5.12	6.25
Return on Total Capital	5.58	6.02	5.65	5.91	7.19
Return On Equity %	9.58	9.5	8.41	8.73	8.68
Return on Common Equity	9.59	9.5	8.41	8.73	8.68
Margin Analysis
Gross Profit Margin %	53.21	52.52	50.89	52.18	54.11
SG&A Margin	26.13	25.42	26.2	37.28	36.71
EBITDA Margin %	24.66	24.96	23.17	21.44	23.65
EBITA Margin %	15.87	16.59	14.61	17.36	19.64
EBIT Margin %	15.87	16.59	14.61	15.25	17.65
Income From Continuing Operations Margin %	12.58	12.63	10.89	11.54	11.29
Net Income Margin %	12.59	12.63	10.89	11.54	11.29
Net Avail. For Common Margin %	12.59	12.63	10.89	11.54	11.29
Normalized Net Income Margin	10.01	10.36	9.16	9.59	10.84
Levered Free Cash Flow Margin	1.34	4.87	3.66	0.88	12.97
Unlevered Free Cash Flow Margin	1.56	5.02	3.83	1.02	13.09
Asset Turnover
Asset Turnover	0.47	0.5	0.53	0.54	0.57
Fixed Assets Turnover	2.18	2.22	2.33	2.34	2.45
Receivables Turnover (Average Receivables)	4.71	5.31	5.72	5.87	6.12
Inventory Turnover (Average Inventory)	1.78	1.79	1.8	1.64	1.64
Short Term Liquidity
Current Ratio	2.48	3.14	2.8	1.9	3
Quick Ratio	1.56	1.92	1.56	1.02	1.67
Operating Cash Flow to Current Liabilities	0.57	0.8	0.54	0.39	0.87
Days Sales Outstanding (Average Receivables)	77.45	68.7	63.78	62.36	59.63
Days Outstanding Inventory (Average Inventory)	205.06	204.44	203.03	222.6	222.98
Average Days Payable Outstanding	99.2	84.4	72.08	40.16	38.4
Cash Conversion Cycle (Average Days)	183.31	188.74	194.73	244.79	244.21
Long Term Solvency
Total Debt/Equity	34.21	25.59	24	20.24	15.63
Total Debt / Total Capital	25.49	20.37	19.36	16.83	13.52
LT Debt/Equity	28.56	24.91	22.38	7.86	13.99
Long-Term Debt / Total Capital	21.28	19.83	18.05	6.54	12.1
Total Liabilities / Total Assets	36.6	31.31	30.65	27.54	25.15
EBIT / Interest Expense	44.05	71.22	53.72	68.07	90.73
EBITDA / Interest Expense	68.43	107.17	85.22	98.89	125.2
(EBITDA - Capex) / Interest Expense	40.26	74.5	61.58	69.48	91.16
Total Debt / EBITDA	1.94	1.48	1.4	1.32	0.85
Net Debt / EBITDA	0.61	0.31	0.42	0.3	-0.03
Total Debt / (EBITDA - Capex)	3.29	2.12	1.94	1.87	1.16
Net Debt / (EBITDA - Capex)	1.04	0.44	0.58	0.43	-0.04
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-2.39	14.57	16.62	12.39	12.4
Gross Profit, 1 Yr. Growth %	-5.03	13.08	13	15.25	16.55
EBITDA, 1 Yr. Growth %	-6.68	15.97	8.25	12.02	23.96
EBITA, 1 Yr. Growth %	-11.29	19.73	2.68	12.4	27.18
EBIT, 1 Yr. Growth %	-11.29	19.73	2.68	13.48	30.13
Earnings From Cont. Operations, 1 Yr. Growth %	-9.22	15.04	0.58	19.09	9.97
Net Income, 1 Yr. Growth %	-9.32	14.94	0.58	19.09	9.97
Normalized Net Income, 1 Yr. Growth %	-9.38	18.53	3.07	15.57	27.14
Diluted EPS Before Extra, 1 Yr. Growth %	-9.33	14.95	1.34	20.16	10.52
Accounts Receivable, 1 Yr. Growth %	-2.25	5.61	10.76	17.88	-0.8
Inventory, 1 Yr. Growth %	19.32	13.08	25.73	14.82	2.72
Net Property, Plant and Equip., 1 Yr. Growth %	13.34	11.41	11.08	12.13	3.66
Total Assets, 1 Yr. Growth %	8.85	9.07	8.72	14.3	-0.16
Tangible Book Value, 1 Yr. Growth %	31.2	29.28	15.14	27.59	9.44
Common Equity, 1 Yr. Growth %	13.49	18.17	9.75	19.44	3.12
Cash From Operations, 1 Yr. Growth %	3.41	16.45	-16.92	24.5	44.06
Capital Expenditures, 1 Yr. Growth %	0	-14.13	-1.53	15.24	12.99
Levered Free Cash Flow, 1 Yr. Growth %	-73.83	317.92	-12.35	-70.36	1.57T
Unlevered Free Cash Flow, 1 Yr. Growth %	-70.49	268.32	-10.95	-67.29	1.35T
Dividend Per Share, 1 Yr. Growth %	3.57	17.24	17.65	10	18.18
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.19	5.75	15.59	14.49	12.4
Gross Profit, 2 Yr. CAGR %	0.02	3.63	13.04	14.12	15.9
EBITDA, 2 Yr. CAGR %	1.33	4.03	12.04	6.33	17.84
EBITA, 2 Yr. CAGR %	-2.92	3.06	10.88	17.46	19.56
EBIT, 2 Yr. CAGR %	-2.92	3.06	10.88	10.1	21.52
Earnings From Cont. Operations, 2 Yr. CAGR %	-1.32	2.2	7.57	9.44	14.44
Net Income, 2 Yr. CAGR %	-1.4	2.09	7.52	9.44	14.44
Normalized Net Income, 2 Yr. CAGR %	-2.39	3.64	10.53	11.13	21.22
Diluted EPS Before Extra, 2 Yr. CAGR %	-1.37	2.1	7.93	10.35	15.24
Accounts Receivable, 2 Yr. CAGR %	0.12	1.61	8.16	11.79	8.14
Inventory, 2 Yr. CAGR %	14.42	16.16	19.24	20.15	8.6
Net Property, Plant and Equip., 2 Yr. CAGR %	21.81	12.37	11.25	11.6	7.81
Total Assets, 2 Yr. CAGR %	9.8	8.96	8.89	11.48	6.82
Tangible Book Value, 2 Yr. CAGR %	29.59	30.24	22.01	27.2	18.17
Common Equity, 2 Yr. CAGR %	10.78	15.81	13.88	14.5	10.98
Cash From Operations, 2 Yr. CAGR %	13.94	9.74	-1.64	1.7	33.92
Capital Expenditures, 2 Yr. CAGR %	25.88	-7.33	-8.04	6.53	14.11
Levered Free Cash Flow, 2 Yr. CAGR %	-49.13	4.58	91.39	-	122.17
Unlevered Free Cash Flow, 2 Yr. CAGR %	-46.08	4.25	81.11	-	117.7
Dividend Per Share, 2 Yr. CAGR %	3.64	10.19	17.44	13.76	14.02
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.46	5.47	9.26	-	13.79
Gross Profit, 3 Yr. CAGR %	0.76	4.2	6.66	-	14.93
EBITDA, 3 Yr. CAGR %	0.29	5.99	5.42	-	11.91
EBITA, 3 Yr. CAGR %	-3.38	4.1	2.93	-	20.62
EBIT, 3 Yr. CAGR %	-3.38	4.1	2.93	-	16.41
Earnings From Cont. Operations, 3 Yr. CAGR %	-5.4	3.85	1.65	-	9.62
Net Income, 3 Yr. CAGR %	-5.41	3.77	1.58	-	9.62
Normalized Net Income, 3 Yr. CAGR %	-3.12	4.13	3.45	-	16.23
Diluted EPS Before Extra, 3 Yr. CAGR %	-5.51	3.8	1.84	-	10.41
Accounts Receivable, 3 Yr. CAGR %	1.98	1.92	4.57	-	7.42
Inventory, 3 Yr. CAGR %	16.14	13.97	19.26	-	14.03
Net Property, Plant and Equip., 3 Yr. CAGR %	18.7	18.24	11.94	-	8.89
Total Assets, 3 Yr. CAGR %	7.79	9.55	8.88	-	7.45
Tangible Book Value, 3 Yr. CAGR %	52.9	29.49	25	-	20.98
Common Equity, 3 Yr. CAGR %	15.9	13.19	13.75	-	10.57
Cash From Operations, 3 Yr. CAGR %	1.98	14.77	0.02	-	14.22
Capital Expenditures, 3 Yr. CAGR %	25.05	10.82	-5.44	-	8.64
Levered Free Cash Flow, 3 Yr. CAGR %	-54.34	2.65	-1.4	-	-
Unlevered Free Cash Flow, 3 Yr. CAGR %	-52.11	2.3	-1.09	-	-
Dividend Per Share, 3 Yr. CAGR %	5.07	7.99	12.62	-	15.21
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.18	6.47	6.89	-	-
Gross Profit, 5 Yr. CAGR %	2.77	5.85	5.5	-	-
EBITDA, 5 Yr. CAGR %	3.68	7.55	4.83	-	-
EBITA, 5 Yr. CAGR %	1	6.11	2.09	-	-
EBIT, 5 Yr. CAGR %	3.59	9.1	2.09	-	-
Earnings From Cont. Operations, 5 Yr. CAGR %	8.8	10.42	-0.41	-	-
Net Income, 5 Yr. CAGR %	8.8	10.37	-0.44	-	-
Normalized Net Income, 5 Yr. CAGR %	6.07	10.87	2.12	-	-
Diluted EPS Before Extra, 5 Yr. CAGR %	10.08	10.89	-0.35	-	-
Accounts Receivable, 5 Yr. CAGR %	4.56	4.7	4.41	-	-
Inventory, 5 Yr. CAGR %	12.73	13.22	17.37	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	11.26	12.76	15.66	-	-
Total Assets, 5 Yr. CAGR %	8.43	7.61	8.23	-	-
Tangible Book Value, 5 Yr. CAGR %	11.74	70.3	39.7	-	-
Common Equity, 5 Yr. CAGR %	10.87	15.64	15.09	-	-
Cash From Operations, 5 Yr. CAGR %	8.63	11.84	0.51	-	-
Capital Expenditures, 5 Yr. CAGR %	17.18	12.39	10.58	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-32.28	-6.4	-19	-	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-30.35	-6.14	-18.47	-	-
Dividend Per Share, 5 Yr. CAGR %	8.26	10.12	9.86	-	-